Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares
-
Travere Therapeutics Submits Supplemental New Drug Application to the U.S. Food and Drug Administration Seeking Full Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy (IgAN)
-
Manhattan Bridge Capital, Inc. Reports Results for 2023
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Direct Line Insurance Group plc - Ordinary Shares
-
Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities
-
Dimensional Fund Advisors Ltd. : Form 8.3 - CUSTODIAN PROPERTY INCOME RE - Ordinary Shares
-
Microbix Unveils Test Controls for Head and Neck Cancer
-
Corporate Update: Meni Morim to Step Down as CEO
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
-
Clarus Files Lawsuit Against Caption Management LLC, Caption Partners II LP, Caption GP, LLC, William Cooper and Jason Strasser for Recovery of Short-Swing Profits
-
Praluent® (alirocumab) Injection Receives FDA Approval to Treat Children with Genetic Form of High Cholesterol
-
Abaxx Prepares Exchange Opening Sequence and Final Notices
-
Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division
-
Cielo Announces Closing of First Tranche of Private Placement of Convertible Debenture Units
-
Emerita Intersects 68.9 Meters Grading 0.7% Copper; 0.3% Lead; 0.5% Zinc, 0.91 g/t Gold and 36.2 g/t Silver, Including 9.4 Meters Grading 0.9% Copper; 0.3% Lead; 1.4% Zinc, 1.59 g/t Gold and 37.8 g/t
-
Pulsar Helium Special Virtual Conference Today Register Now
-
Plus Therapeutics Completes Dosing in Cohort 5 of ReSPECT-LM Phase 1 Trial of Rhenium (186Re) Obisbemeda in Leptomeningeal Metastases
-
Lantronix to Participate in 36th Annual Roth Conference Held March 17–19, 2024
-
Monte Rosa Therapeutics Announces Initiation of IND Enabling Studies for MRT-8102, A First-in-Class NEK7 Directed Molecular Glue Degrader and NLRP3/IL-1β Pathway Inhibitor
-
Ventyx Biosciences Reports Clinical Data for its NLRP3 Inhibitor Portfolio and Provides Pipeline Updates at Virtual Investor Event
-
Plymouth Industrial REIT Development Projects in Jacksonville Earn Green Globes® Certification for Core & Shell Construction
-
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®
-
FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer
-
Lexicon Preparing to Resubmit Sotagliflozin NDA for Type 1 Diabetes Following Feedback From FDA
-
Arvig to Invest Grant Funding in $5 Million Fiber Expansion for 3 Minnesota Counties
-
mdf commerce enters definitive agreement to be acquired by KKR
-
ASLAN Pharmaceuticals Provides TREK-DX Study Update and Highlights Potential of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients
-
Tower Semiconductor to Present at 2024 SEMICON China Addressing Advanced CMOS Process Technology for Micro Displays
-
Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation
-
Smart Share Global Limited Declares a Special Cash Dividend
-
Tecnoglass to Present at the Sidoti Virtual Small Cap Conference
-
Autolus Therapeutics announces publication in Blood Cancer Journal
-
Akoustis to Attend the 36th Annual Roth Conference on March 17-19, 2024
-
Amplify Energy Update on Southern California Oil Sheen
-
ProMIS Neurosciences Strengthens Global Intellectual Property Portfolio
-
Nurix Therapeutics Announces U.S. FDA Lifts Partial Clinical Hold on NX-2127 Phase 1 Trial
-
Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor
-
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®
-
Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub
-
Senior Business Leader Joins SMU Cox Spears Institute for Entrepreneurial Leadership
-
CareCloud to Showcase its Generative AI Solutions and Tech-Enabled RCM at the 2024 HIMSS Conference and Exhibition
-
Ceco Environmental to Participate in the 36th Annual Roth Conference on March 18
-
Cory Gitt Joins BridgeCore Capital as Managing Director, Loan Originations
-
DISQO’s Cross-Media Ad Measurement Now Amplified By Inscape’s Smart TV Viewing Data
-
Eyenovia to Report Fourth Quarter 2023 Results and Provide Business Update on Monday, March 18th
-
AIChE and IChemE Announce Webinar Series and Annual Conference to Advance Hydrogen as an Energy Carrier
-
CivicLab Appoints Newest Fellow
-
Resonant Link Demonstrates Automated Wireless Charging at MODEX
-
Replay’s cell therapy product company Syena announces first patient dosed in Phase 1/2 study of TCR-NK cell therapy for multiple myeloma
-
Rego Payment Architectures, Inc. Launches Accessibility Features for the Visually Impaired

